334 related articles for article (PubMed ID: 22409994)
1. Drug resistance: still a daunting challenge to the successful treatment of AML.
Shaffer BC; Gillet JP; Patel C; Baer MR; Bates SE; Gottesman MM
Drug Resist Updat; 2012; 15(1-2):62-9. PubMed ID: 22409994
[TBL] [Abstract][Full Text] [Related]
2. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.
Hawley TS; Riz I; Yang W; Wakabayashi Y; Depalma L; Chang YT; Peng W; Zhu J; Hawley RG
Am J Hematol; 2013 Apr; 88(4):265-72. PubMed ID: 23475625
[TBL] [Abstract][Full Text] [Related]
3. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
4. Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies.
Mahadevan D; List AF
Blood; 2004 Oct; 104(7):1940-51. PubMed ID: 15217827
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
6. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
Natarajan K; Bhullar J; Shukla S; Burcu M; Chen ZS; Ambudkar SV; Baer MR
Biochem Pharmacol; 2013 Feb; 85(4):514-24. PubMed ID: 23261525
[TBL] [Abstract][Full Text] [Related]
7. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib antagonizes ABC transporters in acute myeloid leukemia.
Lainey E; Sébert M; Thépot S; Scoazec M; Bouteloup C; Leroy C; De Botton S; Galluzzi L; Fenaux P; Kroemer G
Cell Cycle; 2012 Nov; 11(21):4079-92. PubMed ID: 23095522
[TBL] [Abstract][Full Text] [Related]
9. A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia.
Williams MS; Amaral FM; Simeoni F; Somervaille TC
J Clin Invest; 2020 Mar; 130(3):1217-1232. PubMed ID: 31770110
[TBL] [Abstract][Full Text] [Related]
10. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia.
Marcelletti JF; Sikic BI; Cripe LD; Paietta E
Cytometry B Clin Cytom; 2019 Jan; 96(1):57-66. PubMed ID: 30334334
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients.
Scheiner MA; da Cunha Vasconcelos F; da Matta RR; Dal Bello Figueira R; Maia RC
J Cancer Res Clin Oncol; 2012 Jun; 138(6):959-69. PubMed ID: 22358301
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
Grundy M; Seedhouse C; Russell NH; Pallis M
BMC Cancer; 2011 Jun; 11():254. PubMed ID: 21679421
[TBL] [Abstract][Full Text] [Related]
14. The role of drug efflux pumps in acute myeloid leukemia.
van der Kolk DM; de Vries EG; Müller M; Vellenga E
Leuk Lymphoma; 2002 Apr; 43(4):685-701. PubMed ID: 12153153
[TBL] [Abstract][Full Text] [Related]
15. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Amiri-Kordestani L; Basseville A; Kurdziel K; Fojo AT; Bates SE
Drug Resist Updat; 2012; 15(1-2):50-61. PubMed ID: 22464282
[TBL] [Abstract][Full Text] [Related]
16. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
Leith CP; Chen IM; Kopecky KJ; Appelbaum FR; Head DR; Godwin JE; Weick JK; Willman CL
Blood; 1995 Sep; 86(6):2329-42. PubMed ID: 7545025
[TBL] [Abstract][Full Text] [Related]
17. The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations.
Mathias TJ; Natarajan K; Shukla S; Doshi KA; Singh ZN; Ambudkar SV; Baer MR
Invest New Drugs; 2015 Apr; 33(2):300-9. PubMed ID: 25597754
[TBL] [Abstract][Full Text] [Related]
18. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).
Tang R; Faussat AM; Perrot JY; Marjanovic Z; Cohen S; Storme T; Morjani H; Legrand O; Marie JP
BMC Cancer; 2008 Feb; 8():51. PubMed ID: 18271955
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
